Menu
Recruiting NCT04320680

Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation

No phase Interventional Systemic Lupus Erythematosus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: description of a lupus patient cohort.
Who it may be relevant to
Registry conditions: Systemic Lupus Erythematosus. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Cohort Follow-up of Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation at the CHRU of Brest

Overview

Diagnosis and follow up of a lupus cohort in a multidisciplinary consultation in Brest ( France)

Detailed description

all patients coming to the LUPUS multidisciplinary consultation in brest ( France) will have a clinical examination, a biological and immunogical blood samples, cutaneous biopsies or renal biospies if necessary, an ultrasonographic articular and salivary glandular examination if needed. In case of articular involvement, some Xrays ( hands and feet) will be done at the inclusion and during the follow up each year during 5 years .

Interventions

  • Other description of a lupus patient cohort
    description of a lupus patient cohort

Primary outcome measures

  • Cohort lupus: epidemiologic lupus study about diagnosis and follow up [Time frame: five years]

Eligibility criteria

Inclusion criteria

  • women or men, more than 18 years old, coming to the multidisciplinary consultation in brest ( France).
  • With written consentment

Exclusion criteria

  • patients less than 18 years old
  • refusing to participate
  • Under legal protection

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

France · 1 center
  • CHRU de Brest — Brest

Identifiers

NCT: NCT04320680 · 29BRC20.0073

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗